LOS ANGELES--(BUSINESS WIRE)--
j2 Global, Inc. (NASDAQ: JCOM), the global provider of Internet services
and digital media, announced today that the Company completed two
acquisitions in the third quarter of 2017, spanning two business units
and two countries.

Terms of the individual acquisitions were not disclosed, and the
financial impact to j2 is not expected to be material with respect to
those acquisitions.

As previously announced, j2 sold Cambridge BioMarketing LLC, a
subsidiary of Everyday Health, Inc. In addition, j2 announced that it
has sold Web24, its Australian hosting business, and Tea Leaves Health,
LLC, a subsidiary of Everyday Health, Inc.

In light of the three divestitures described above, which reduce the
Company's revenue by approximately $23 million in the second half of the
year, j2 announced that it is adjusting its revenue guidance for fiscal
year 2017 as follows: for fiscal 2017, j2 estimates that it will achieve
revenues between $1.107 billion and $1.147 billion. j2 reaffirms its
Adjusted non-GAAP earnings per diluted share of between $5.60 and $6.00.

Adjusted non-GAAP earnings per diluted share for 2017 excludes
share-based compensation of between $21 million and $23 million,
amortization of acquired intangibles and the impact of any currently
unanticipated items, in each case net of tax. The increase in
share-based compensation is due to the recent announcement of Hemi
Zucker's retirement from j2 and the expected acceleration of equity
related thereto.

It is anticipated that the non-GAAP effective tax rate for 2017
(exclusive of the release of reserves for uncertain tax positions) will
be between 28.5% and 30.5%.

The Company has not reconciled the Adjusted non-GAAP earnings per
diluted share and tax rate guidance included in this release to the most
directly comparable GAAP measure because this cannot be done without
unreasonable effort due to the variability with respect to costs related
to acquisitions and taxation, which are potential adjustments to future
earnings. We expect the variability of these items to have a potentially
unpredictable and significant impact on our future GAAP financial
results.